SBRT Appears Effective for Oligometastatic Prostate Cancer August 10, 2018 Stereotactic body radiation therapy (SBRT) appears to be an effective treatment for oligometastatic disease in patients with recurrent prostate cancer, a new study suggests. Ciro Franzese, MD, of Humanitas Clinical and Research Hospital, and colleagues analyzed findings from 64 patients who underwent SBRT for 90 metastases.Read more.Source: Cancer Therapy Advisor Prostate Cancer News
Stereotactic body radiation therapy (SBRT) appears to be an effective treatment for oligometastatic disease in patients with recurrent prostate cancer, a new study suggests. Ciro Franzese, MD, of Humanitas Clinical and Research Hospital, and colleagues analyzed findings from 64 patients who underwent SBRT for 90 metastases.Read more.Source: Cancer Therapy Advisor
